Accuracy of smartwatch electrocardiographic recording in the acute coronary syndrome setting: rationale and design of the ACS WATCH II Study

dc.contributor.authorBuelga Suárez, Mauro
dc.contributor.authorPascual Izco, Marina
dc.contributor.authorGarcía Montalvo, Jesús
dc.contributor.authorAlonso Salinas, Gonzalo Luis
dc.contributor.departmentCiencias de la Saludes_ES
dc.contributor.departmentOsasun Zientziakeu
dc.date.accessioned2024-03-22T11:12:30Z
dc.date.available2024-03-22T11:12:30Z
dc.date.issued2024
dc.date.updated2024-03-22T10:39:51Z
dc.description.abstractBackground: Acute Coronary Syndrome (ACS), with or without ST-segment elevation, is a major contributor to global mortality and morbidity. Swift diagnosis and treatment are vital for mitigating cardiac damage and improving long-term outcomes. The 12-lead electrocardiogram (ECG) currently serves as the gold standard for diagnosis in ACS with ST-segment elevation and may support the diagnosis in ACS without ST-segment elevation. However, the growing prevalence of smartwatches enables the acquisition of electrocardiographic data without traditional ECG equipment. While smaller studies support smartwatch ECG use, larger-scale validation within ACS remains lacking. The ACS WATCH II study aims to validate smartwatch ECG recordings for ACS. Methods: The primary objective is to validate smartwatch-obtained electrocardiographic data in patients presenting with ACS. Two cohorts of 120 patients each, presenting ACS with and without ST-segment elevation, will be assessed. Smartwatches will capture recordings of leads I, III, and V2 alongside standard ECGs. These leads, chosen due to a 97% ACS diagnosis sensitivity in previous studies, will undergo blind evaluation by two experienced external assessors against conventional ECG. Additionally, a control sample of 60 healthy individuals will be included. Conclusions: ACS WATCH II pioneers large-scale prospective validation of smartwatch ECG recordings in ACS patients. Additionally, it indirectly validates a swift diagnostic approach using three leads (I, III, and V2). This could expedite time-critical ACS diagnoses and simplify access through smartwatch-based diagnosis.es_ES
dc.format.mimetypeapplication/pdfen
dc.identifier.citationBuelga Suárez, M., Pascual Izco, M., García Montalvo, J., Alonso Salinas, G. L. (2024) Accuracy of smartwatch electrocardiographic recording in the acute coronary syndrome setting: Rationale and design of the ACS WATCH II Study. Journal of Clinical Medicine, 13(2), 1-8. https://doi.org/10.3390/jcm13020389.es_ES
dc.identifier.doi10.3390/jcm13020389
dc.identifier.issn2077-0383
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/47762
dc.language.isoengen
dc.publisherMDPIen
dc.relation.ispartofJournal of Clinical Medicine (2024), vol. 3, núm. 2es_ES
dc.relation.publisherversionhttps://doi.org/10.3390/jcm13020389
dc.rights© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAcute coronary syndromeen
dc.subjectAcute myocardial infarctionen
dc.subjectECG tracingen
dc.subjectIschemic heart diseaseen
dc.subjectNSTEMIen
dc.subjectSmartwatchen
dc.subjectSTEMIen
dc.titleAccuracy of smartwatch electrocardiographic recording in the acute coronary syndrome setting: rationale and design of the ACS WATCH II Studyen
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication
relation.isAuthorOfPublication19594984-6f7d-48a8-88f0-b5e35ccebb77
relation.isAuthorOfPublication.latestForDiscovery19594984-6f7d-48a8-88f0-b5e35ccebb77

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Buelga_AccuracySmartwatch.pdf
Size:
208.71 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.78 KB
Format:
Item-specific license agreed to upon submission
Description: